scholarly journals Joint effect of mid- and late-life blood pressure on the brain: The AGES-Reykjavik Study

Neurology ◽  
2014 ◽  
Vol 83 (9) ◽  
pp. 867-867
Neurology ◽  
2014 ◽  
Vol 82 (24) ◽  
pp. 2187-2195 ◽  
Author(s):  
M. Muller ◽  
S. Sigurdsson ◽  
O. Kjartansson ◽  
T. Aspelund ◽  
O. L. Lopez ◽  
...  

Neurology ◽  
2015 ◽  
Vol 84 (3) ◽  
pp. 329-330
Author(s):  
P. Kowal ◽  
K. Charlton ◽  
M. Muller ◽  
L. Launer

Stroke ◽  
2001 ◽  
Vol 32 (12) ◽  
pp. 2882-2889 ◽  
Author(s):  
R. Peila ◽  
L.R. White ◽  
H. Petrovich ◽  
K. Masaki ◽  
G.W. Ross ◽  
...  

2018 ◽  
Vol 25 (28) ◽  
pp. 3333-3352 ◽  
Author(s):  
Natalia Pessoa Rocha ◽  
Ana Cristina Simoes e Silva ◽  
Thiago Ruiz Rodrigues Prestes ◽  
Victor Feracin ◽  
Caroline Amaral Machado ◽  
...  

Background: The Renin-Angiotensin System (RAS) is a key regulator of cardiovascular and renal homeostasis, but also plays important roles in mediating physiological functions in the central nervous system (CNS). The effects of the RAS were classically described as mediated by angiotensin (Ang) II via angiotensin type 1 (AT1) receptors. However, another arm of the RAS formed by the angiotensin converting enzyme 2 (ACE2), Ang-(1-7) and the Mas receptor has been a matter of investigation due to its important physiological roles, usually counterbalancing the classical effects exerted by Ang II. Objective: We aim to provide an overview of effects elicited by the RAS, especially Ang-(1-7), in the brain. We also aim to discuss the therapeutic potential for neuropsychiatric disorders for the modulation of RAS. Method: We carried out an extensive literature search in PubMed central. Results: Within the brain, Ang-(1-7) contributes to the regulation of blood pressure by acting at regions that control cardiovascular functions. In contrast with Ang II, Ang-(1-7) improves baroreflex sensitivity and plays an inhibitory role in hypothalamic noradrenergic neurotransmission. Ang-(1-7) not only exerts effects related to blood pressure regulation, but also acts as a neuroprotective component of the RAS, for instance, by reducing cerebral infarct size, inflammation, oxidative stress and neuronal apoptosis. Conclusion: Pre-clinical evidence supports a relevant role for ACE2/Ang-(1-7)/Mas receptor axis in several neuropsychiatric conditions, including stress-related and mood disorders, cerebrovascular ischemic and hemorrhagic lesions and neurodegenerative diseases. However, very few data are available regarding the ACE2/Ang-(1-7)/Mas receptor axis in human CNS.


2016 ◽  
Vol 119 (12) ◽  
Author(s):  
Esther A.H. Warnert ◽  
Jonathan C.L. Rodrigues ◽  
Amy E. Burchell ◽  
Sandra Neumann ◽  
Laura E.K. Ratcliffe ◽  
...  

2012 ◽  
Vol 8 (4S_Part_3) ◽  
pp. P88-P88 ◽  
Author(s):  
Shahram Oveisgharan ◽  
Alina Solomon ◽  
Miia Kivipelto ◽  
Vladimir Hachinski

2012 ◽  
Vol 302 (3) ◽  
pp. R313-R320 ◽  
Author(s):  
Curt D. Sigmund

The purpose of this review is two-fold. First, I will highlight recent advances in our understanding of the mechanisms regulating angiotensin II (ANG II) synthesis in the brain, focusing on evidence that renin is expressed in the brain and is expressed in two forms: a secreted form, which may catalyze extracellular ANG I generation from glial or neuronal angiotensinogen (AGT), and an intracellular form, which may generate intracellular ANG in neurons that may act as a neurotransmitter. Second, I will discuss recent studies that advance the concept that the renin-angiotensin system (RAS) in the brain not only is a potent regulator of blood pressure and fluid intake but may also regulate metabolism. The efferent pathways regulating the blood pressure/dipsogenic effects and the metabolic effects of elevated central RAS activity appear different, with the former being dependent upon the hypothalamic-pituitary-adrenal axis, and the latter being dependent upon an interaction between the brain and the systemic (or adipose) RAS.


Author(s):  
Hans T. Versmold

Systemic blood pressure (BP) is the product of cardiac output and total peripheral resistance. Cardiac output is controlled by the heart rate, myocardial contractility, preload, and afterload. Vascular resistance (vascular hindrance × viscosity) is under local autoregulation and general neurohumoral control through sympathetic adrenergic innervation and circulating catecholamines. Sympathetic innovation predominates in organs receivingflowin excess of their metabolic demands (skin, splanchnic organs, kidney), while innervation is poor and autoregulation predominates in the brain and heart. The distribution of blood flow depends on the relative resistances of the organ circulations. During stress (hypoxia, low cardiac output), a raise in adrenergic tone and in circulating catecholamines leads to preferential vasoconstriction in highly innervated organs, so that blood flow is directed to the brain and heart. Catecholamines also control the levels of the vasoconstrictors renin, angiotensin II, and vasopressin. These general principles also apply to the neonate.


2014 ◽  
Vol 10 ◽  
pp. P18-P18
Author(s):  
Min Soo Byun ◽  
Young Min Choe ◽  
Bo Kyung Sohn ◽  
Ji Young Han ◽  
Eun Hyun Seo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document